The Food and Drug Administration (FDA) has appointed Timothy Schell, Ph.D., as the new director of the FDA Center for Veterinary Medicine (CVM), where he will lead the regulation of animal food, drugs and devices.
Schell joined the CVM in 2000 as a reviewer of new animal drugs for swine and poultry. He most recently led the CVM's Office of Surveillance and Compliance and has held multiple leadership positions throughout his tenure at the agency, including deputy director of the Division of Animal Feeds from 2009-14 and director and deputy at CVM's Office of Research for more than a year.
Between 2015 and 2019, Schell worked at Elanco Animal Health, where he led regulatory affairs strategies in several areas and expanded the firm's global initiatives in animal drugs and feed additives.
"The AFIA congratulates longtime animal food safety proponent Timothy Schell, Ph.D., on his appointment as director of the FDA's Center for Veterinary Medicine," said Constance Cullman, president and CEO of the American Feed Industry Association (AFIA). "Dr. Schell's long-standing commitment to science-based decision-making and his deep understanding of the myriad animal feed and pet food ingredients and innovations coming to market will serve the industry and consumers well. We look forward to continuing our collaboration with the CVM under his leadership as he implements the Center's Innovation Agenda and ensuring a safe, sustainable and competitive animal food supply."
Schell earned his Master of Science and Ph.D. in animal nutrition at Virginia Polytechnic Institute and State University in Blacksburg, Virginia. He completed his undergraduate degree in animal and dairy sciences at Auburn University.
